Miles Prince

Haematologist and blood cancer researcher. Passionate about Philanthropy through Snowdome Foundation, Maddie Riewoldt Vision, Epworth Foundation and PeterMac

[Snowdome Foundation @SnowdomeAU]

Congratulations to Dr Josh Tobin @JwdTobin from @MaterResearch Institute-The University of Queensland on being awarded the Snowdome Foundation #Haematology Fellowship. Dr Tobin aims to improve outcomes for #follicularlymphoma patients.
#QueenslandUniversity

[Miles Prince @MilesPrince4]

Early days but always good to see hope! https://t.co/62i27tq7a0

[The Daily Edition @DailyEditionOn7]

It's World Blood Donor Day this Sunday, and Australians are being urged to donate to help buy more time for patients in need. #TDE7

[C. Ola Landgren, M.D. @DrOlaLandgren]

Outstanding news today for myeloma patients: FDA approves subcutaneous Daratumumab, DARZALEX FASPRO (daratumumab & hyaluronidase-fihj). Fixed-dose injection given in 3 to 5 minutes. Convenient, safe, effective! #mmsm ⁦@theMMRF⁩ ⁦@IMFmyeloma⁩ https://t.co/BNexNzldT2

[Miles Prince @MilesPrince4]

Join me in stopping the spread of COVID-19! Download COVIDSafe, an app from the Australian Government. #COVID19
#coronavirusaustralia #stayhomesavelives https://t.co/QeCGHapfbs

[Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 @Rfonsi1]

Pretty frustrating to see so much misunderstanding with the antimalarial drugs chloroquine and hydroxychloroquine (C/HC) as presented by politicians and the media. The nuances, which are critical, are lost. My short primer on this.
The "skinny" on C/HQ

1/x
#COVID19

[Urvi Shah @UrviShahMD]

The C word– #Cancer or #COVID19. Up until now most of us feared a cancer diagnosis, Covid19 has quickly taken it's place given the significant strain it is placing on us at every level. Having been diagnosed with both 4 years apart has brought back similar memories. 1/11

[David Zodda, MD @DavidZodda]

I intubated my colleague today, a young, healthy ER doc like me. This is what I learned...

[Multiple Myeloma Hub @MM_Hub]

WATCH 🎥 MRD in #myeloma: Can maintenance with lenalidomide increase MRD-negativity rates? The @MM_Hub spoke to @DrOlaLandgren at the #ASH19 meeting about the latest data from a phase II trial investigating lenalidomide as maintenance therapy: https://t.co/g6JoQgjdEr #mmMRD

[Epworth @Epworth]

In 2020, we'll celebrate 100 years of care.

As we celebrate our centenary, we'll reflect on our past, continue our commitment to care into the future & recognise you, our community, for helping us reach this milestone #Epworth100

[Multiple Myeloma Hub @MM_Hub]

WATCH 🎥 @mvmateos speaks to the @MM_Hub about the efficacy of dara-Kd in patients with R/R #myeloma. Results from the phase III CANDOR trial were presented during the late-breaking abstract session at the #ASH19 meeting in Orlando, US by @szusmani: https://t.co/YKOnMwHvQe #mmsm

[Lymphoma Hub @lymphomahub]

🎥 @StefanoLuminari from @UNIMORE_univ discusses the need for use of geriatric assessment tools to guide treatment decisions for elderly patients with DLBCL and comments on such tools presented during ASH 2019. Also available in Italian. https://t.co/z2x4ivECyF #ASH19 #lymsm

[Multiple Myeloma Hub @MM_Hub]

CONGRESS | #IMW2019 | @DrOlaLandgren presents results of a phase 1b study of once-weekly carfilzomib plus Rd (KRd) in patients with NDMM. KRd (56mg/m^2) feasible and active: response rates comparable to twice weekly dosing in frontline setting. Further evaluations required #mmsm

[Lymphoma Hub @lymphomahub]

CONGRESS | #SOHO2019 | @DrJulieVose from @UNMC talks about new frontline regimens in T-cell lymphoma. #lymsm @lymphomahub

[Miles Prince @MilesPrince4]

Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) Meets Primary Endpoint Of Progression-Free Survival | BioSpace https://t.co/AnwJnelMiw

[BioSpace @biospace]

Even as recently as the 1960s, the five-year survival rate for leukemia was 14%. By 2010, it had increased to 61%. https://t.co/slvcjBEU1x

[Gary Nolan @garymarknolan]

Congratulations @MM_Hub and @sci_ed_support team 🥳👍🏻👌🏻👍🏻

[Multiple Myeloma Hub @MM_Hub]

CONGRESS | #IMW2019 | A pleasure to be welcomed by Boston Mayor @marty_walsh. He spoke about the importance of cancer research and care, and his own experience of having Burkitt lymphoma as a child #mmsm

[Multiple Myeloma Hub @MM_Hub]

The @MM_Hub team have arrived in Boston for #IMW2019! If you are unable to join the conference but would like to stay up-to-date, we will be live tweeting from the workshop so stay tuned 👀 #mmsm